Year | Index | ||||
---|---|---|---|---|---|
Related links: | |||||
1985 | 100.0 | ||||
1986 | 112.2 | ||||
1987 | 158.4 | ||||
1988 | 211.9 | ||||
1989 | 283.1 | ||||
1990 | 384.1 | ||||
1991 | 497.4 | ||||
1992 | 493.1 | ||||
1993 | 425.1 | ||||
1994 | 449.5 | ||||
1995 | 472.9 | ||||
1996 | 535.1 | ||||
1997 | 481.9 | ||||
1998 | 492.9 | ||||
1999 | 526.9 | ||||
2000 | 569.0 | ||||
2001 | 557.1 | ||||
2002 | 465.1 | ||||
2003 | 435.1 | ||||
2004 | 462.9 | ||||
2005 | 474.8 | ||||
2006 | 452.5 | ||||
2007 | 482.8 | ||||
2008 | 508.5 | ||||
2009 | 488.6 | ||||
2010 | 444.3 | ||||
Statistical bulletin 2006: Figure DRD-8 | |||||
Statistical bulletin 2007: Figure DRD-8 | |||||
Statistical bulletin 2008: Figure DRD-8 | |||||
Statistical bulletin 2009: Figure DRD-8 | |||||
Statistical bulletin 2010: Figure DRD-8 | |||||
Statistical bulletin 2011: Figure DRD-8 | |||||
Statistical bulletin 2012: Figure DRD-8 | |||||
See also ‘General notes for interpreting data’ on the Explanatory notes and help page. |
The Member States that joined the EU in 2004 or afterwards are not included in this graphic due to the lack of retrospective data in most of them (before 1996), which would make the trends difficult to interpret.
Index: 1985 = 100 %.
A few countries did not provide data for some years (see Table DRD-2). To correct this situation, the computation method defined in the report ‘European Monitoring Centre for Drugs and Drug Addiction (2001)’ was used. Coordination of the implementation of EMCDDA standard guidelines on drug-related deaths in the EU Member States, and the collection and analysis of information on drug-related deaths. Project CT.99.RTX.04, coordinated by the Trimbos Institute, Lisbon, EMCDDA.
Number of cases per country per year are presented in Table DRD-2.
Reitox national reports 2012, taken from general mortality registries or special registries (forensic or police).
Based on national definitions as presented in methods and definitions for DRD ‘Definitions of acute drug-related deaths in EU Member States’, as used in the EMCDDA European Drug Report (EDR) and reported in Reitox national reports.
Year | 1985 | 1986 | 1987 | 1988 | 1989 | 1990 | 1991 | 1992 | 1993 | 1994 | 1995 | 1996 | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 |
Index | 100.0 | 112.2 | 158.4 | 211.9 | 283.1 | 384.1 | 497.4 | 493.1 | 425.1 | 449.5 | 472.9 | 535.1 | 481.9 | 492.9 | 526.9 | 569.0 | 557.1 | 465.1 | 435.1 | 462.9 | 474.8 | 452.5 | 482.8 | 508.5 | 488.6 | 444.3 |
drdfig8
Demonstration | Reference | Type | Y Axis | X axis | Label | Width (%) | Height (px) | X plotline | Y plotline | Y min,max values | series Markers |
---|---|---|---|---|---|---|---|---|---|---|---|
szrfig1 | column,column,line | Quantity (kg)|Number of seizures$3 | |||||||||
szrfig2 | column,column,line | Quantity (kg)|Number of seizures$3 | |||||||||
gpsfig4a | line | % | 500 | 0,30 | |||||||
gpsfig1 | column | % | 500 | 0,25 | |||||||
gpsfig2 | column,column,point | Contiuation rates %|LTP all adults$3 | 0, | ||||||||
gpsfig18a | distribution | Estimated prevalence (%) | 0 | ||||||||
gpsfig18b | distribution | Estimated prevalence (%) | 0 | ||||||||
gpsfig20 | column | % | 600 | 0,20 | |||||||
dlofig2 | stackedBar | % | 600 | ||||||||
dlofig3 | line | Index (2006 = 100) | 68 | ||||||||
dlofig3$ | pie | 1 135 701 reports (2011) | 30 | ||||||||
dlofig4 | line | Index (2006 = 100) | 68 | ||||||||
dlofig4$ | pie | 915 541 reports (2011) | 30 | ||||||||
dlofig5 | line | Index (2006 = 100) | 68 | ||||||||
dlofig5$ | pie | 179 418 reports (2011) | 30 | ||||||||
drdfig12a | scatter | Ratio between DRD in 2003 and 2000 | Number of DRD in 2000 | 1 | |||||||
drdfig12b | scatter | Ratio between DRD in 2010/11 and 2003 | Number of DRD in 2003 | 1 | |||||||
hsrfig2 | stackedColumn | Clients in substitution treatment | |||||||||
dlofig1 | line | Index (2006 = 100) | 60,180 | ||||||||
drdfig1 | column | Country and total number of DRD | 600 | ||||||||
drdfig2 | column | Proportion of DRD under the age of 25 (%) | 600 | ||||||||
drdfig3 | line | Mean age in years | |||||||||
drdfig4 | line | Mean age in years | |||||||||
drdfig5a | line | Index (1990 = 100) | |||||||||
drdfig5b | line | Index (1996 = 100) | |||||||||
drdfig6 | line | Index (1990 = 100 %) | 80,160 | ||||||||
drdfig7a | column | Mortality rate per million | |||||||||
drdfig7b | column,point | Rate per million | |||||||||
drdfig8 | line | Index (1985 = 100 %) | 50,650 | ||||||||
drdfig9a | line | % | 0,70 | ||||||||
drdfig9b | line | % | |||||||||
drdfig9c | line | % | |||||||||
drdfig10 | column | Mean age in years | 500 | ||||||||
drdfig11a | line | Index | 0,300 | ||||||||
drdfig11b | line | Index | |||||||||
drdfig11c | line | Index | |||||||||
drdfig13a | line | Number of cases | |||||||||
drdfig13b | line | Number of cases | |||||||||
eyefig1a | line | ||||||||||
eyefig1b | line | ||||||||||
eyefig1c | line | 0, | |||||||||
eyefig1d | line | % | 45 | 800 | |||||||
eyefig1d$ | line | % | 45 | 800 | |||||||
gpsfig3 | column | % | 500 | ||||||||
gpsfig4b | line | % | |||||||||
gpsfig5 | column | % | |||||||||
gpsfig6 | column | % | |||||||||
gpsfig7 | column | % | |||||||||
gpsfig8a | line | % | 0, | ||||||||
gpsfig8b | line | % | 0, | ||||||||
gpsfig9a | column | % | |||||||||
gpsfig9b | column | % | |||||||||
gpsfig10 | line | % | |||||||||
gpsfig11 | column,column,point | Continuation rates (%)| LTP All adults$3 | |||||||||
gpsfig12a | line | % | 0, | ||||||||
gpsfig12b | line | % | 0, | ||||||||
gpsfig13 | column,column,point | % | |||||||||
gpsfig14a | line | % | 0, | ||||||||
gpsfig14b | line | % | 0, | ||||||||
gpsfig15 | column | % | |||||||||
gpsfig16 | column,column,point | Continuation rates (%)|LTP All adults$3 | 0, | ||||||||
gpsfig17 | column | % | |||||||||
gpsfig21a | line | % | 0, | ||||||||
gpsfig21b | line | % | 0, | ||||||||
gpsfig22 | column,column,point | Continuation rates (%)| LTP All adults$3 | |||||||||
gpsfig23a | line | % | |||||||||
gpsfig23b | line | % | |||||||||
gpsfig23c | line | % | |||||||||
gpsfig23d | line | % | 0, | ||||||||
gpsfig23e | line | % | 0, | ||||||||
hsrfig4 | pie | % of prison population in OST | 30 | ||||||||
inffig1a | line | New AIDS cases per million population | 700 | 0, | |||||||
inffig1b | line | New AIDS cases per million population | 700 | 0, | |||||||
inffig2a | line | Cases per million population | 0, | ||||||||
inffig2b | line | Cases per million population | 0, | ||||||||
inffig2c | line | Cases per million population | |||||||||
inffig2d | line | Cases per million population | |||||||||
inffig3a | distribution | % | 0, | National;Subnational|square;rgba(0,0,0,0.8);triangle;rgba(0,0,255,0.8) | |||||||
inffig3b | distribution | % | 0, | National;Subnational|square;rgba(0,0,0,0.8);triangle;rgba(0,0,255,0.8) | |||||||
inffig3c | distribution | % | 0, | National;Subnational|square;rgba(0,0,0,0.8);triangle;rgba(0,0,255,0.8) | |||||||
inffig6a | distribution | % | 0, | National;Subnational|square;rgba(0,0,0,0.8);triangle;rgba(0,0,255,0.8) | |||||||
inffig6b | distribution | % | 0, | National;Subnational|square;rgba(0,0,0,0.8);triangle;rgba(0,0,255,0.8) | |||||||
inffig6c | distribution | % | 0, | National;Subnational|square;rgba(0,0,0,0.8);triangle;rgba(0,0,255,0.8) | |||||||
inffig9a | distribution | % | 0, | National;Subnational|square;rgba(0,0,0,0.8);triangle;rgba(0,0,255,0.8) | |||||||
inffig9b | distribution | % | 0, | National;Subnational|square;rgba(0,0,0,0.8);triangle;rgba(0,0,255,0.8) | |||||||
pppfig1 | line | Index (2005 = 100) | |||||||||
pppfig2 | line | Index (2005 = 100) | |||||||||
tdifig1a | line | % | |||||||||
tdifig1b | line | ||||||||||
tdifig2a | pie | 30 | |||||||||
tdifig2b | pie | 50 | |||||||||
tdifig3a | line | % | |||||||||
tdifig3b | line | ||||||||||
tdifig7 | line | % | 60 | 0, | |||||||
tdifig7$ | stackedColumn | Numbers | 38 | 0,50000 | |||||||
hsrfig1b | stackedColumn | % | |||||||||
Distirbuted points with specific markers and colours | inffig6a | distribution | % | National;Subnational|square;rgba(0,0,0,0.8);triangle;rgba(0,0,255,0.8) | |||||||
The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is the reference point on drugs and drug addiction information in Europe. Inaugurated in Lisbon in 1995, it is one of the EU's decentralised agencies. Read more >>
EMCDDA
Praça Europa 1, Cais do Sodré
1249-289 Lisbon
Portugal
Tel. (351) 211 21 02 00
Fax (351) 218 13 17 11
Page last updated: Friday, 26 April 2013